Hosted on MSN
As the GLP-1 race heats up, how can investors position themselves for the next wave of innovation?
Investors Should Know: The GLP-1 and broader metabolic disease drug space is advancing rapidly, with next-generation oral formulations, triple-acting compounds, and combination therapies moving ...
Biotechnology has long relied on a handful of model microorganisms, such as Escherichia coli and Saccharomyces cerevisiae, whose genetics and physiology are ...
Fintel reports that on August 31, 2023, Cantor Fitzgerald reiterated coverage of Portage Biotech (NASDAQ:PRTG) with a Overweight recommendation. As of August 31, 2023, the average one-year price ...
Biotechnology recruiting is hot. It''s more active than IT and telecommunications and it isn''t suffering the shortages in other areas of healthcare, says Frank Heasley, PhD, President and CEO, of ...
Fintel reports that on August 15, 2023, Morgan Stanley maintained coverage of IO Biotech (NASDAQ:IOBT) with a Overweight recommendation. As of August 2, 2023, the average one-year price target for IO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results